Mount Sinai Researchers Develop Treatment That Turns Tumors Into Cancer Vaccine Factories
April 08, 2019
April 08, 2019
NEW YORK, April 8 -- The Ichan School of Medicine at Mount Sinai issued the following news release:
Researchers at Mount Sinai have developed a novel approach to cancer immunotherapy, injecting immune stimulants directly into a tumor to teach the immune system to destroy it and other tumor cells throughout the body.
The "in situ vaccination" worked so well in patients with advanced-stage lymphoma that it is also undergoing trials in breast and head and neck c . . .
Researchers at Mount Sinai have developed a novel approach to cancer immunotherapy, injecting immune stimulants directly into a tumor to teach the immune system to destroy it and other tumor cells throughout the body.
The "in situ vaccination" worked so well in patients with advanced-stage lymphoma that it is also undergoing trials in breast and head and neck c . . .